Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+159.1%
5Y CAGR+46.9%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+159.1%/yr
Annual compound
5Y CAGR
+46.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.8x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 151.00% |
| 2024 | 85.18% |
| 2023 | -15.57% |
| 2022 | 8.68% |
| 2021 | -240.08% |
| 2020 | 22.05% |
| 2019 | -62.17% |
| 2018 | -181.66% |
| 2017 | -79.19% |
| 2016 | -37.90% |